Amgen trial to evaluate cardiovascular impact of anemia treatment in CKD patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
DIALYSIS & TRANSPLANTATION | 2004年 / 33卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R318 [生物医学工程];
学科分类号：
0831 ;
摘要：
引用
收藏
页码：756 / 756
页数：1
相关论文
共 50 条
  • [21] Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes
    Khavandi, Maryam
    Duarte, Francisco
    Ginsberg, Henry N.
    Reyes-Soffer, Gissette
    CURRENT CARDIOLOGY REPORTS, 2017, 19 (01)
  • [22] Causes of Death in Patients With Anemia of CKD (With/Without Diabetes Mellitus) in the ASCEND-ND Trial
    Singh, Ajay K.
    Aarup, Michael
    Claggett, Brian
    Cobitz, Alexander R.
    Dobronravov, Vladimir A.
    Hutchison, Colin A.
    Juillard, Laurent
    Maes, Bart D.
    Mallett, Stephen
    Pani, Antonello
    Ots-Rosenberg, Mai
    Shaddinger, Bonnie
    Strutz, Frank M.
    Vervloet, Marc G.
    Wanner, Christoph
    Wiecek, Andrzej
    McMurray, John
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 241 - 242
  • [23] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Rohit Singhal
    Lisa Aimee Hechanova
    Current Cardiology Reports, 2022, 24 : 183 - 189
  • [24] SGLT2 Inhibitors: Benefits for CKD and Cardiovascular Disease in Type 2 Diabetes
    Singhal, Rohit
    Hechanova, Lisa Aimee
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (03) : 183 - 189
  • [25] EFFECT OF DAPAGLIFLOZIN ON ALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES AND CKD
    Abdullaev, Sherzod
    Sharapov, Olimkhon
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I685 - I686
  • [26] Finerenone in Patients with CKD and Type 2 Diabetes by SGLT-2i Treatment: The FIDELITY Analysis
    Rossing, Peter
    Filippatos, Gerasimos
    Bakris, George L.
    Anker, Stefan D.
    Pitt, Bertram
    Ruilope, Luis M.
    Gebel, Martin
    Scheerer, Markus
    Roberts, Luke
    Joseph, Amer
    Agarwal, Rajiv
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 45 - 45
  • [27] Evidence for Good Cardiovascular Outcomes among Patients with Type 2 Diabetes, and Promising Treatment for Patients with Type 1 Diabetes
    Ryan, John G.
    CLINICAL THERAPEUTICS, 2016, 38 (06) : 1274 - 1278
  • [28] PHARMACOLOGICAL MANAGEMENT OF TYPE 2 DIABETES MELLITUS IN PATIENTS WITH CKD
    Hamilton, Catherine A.
    JOURNAL OF RENAL CARE, 2012, 38 : 59 - 66
  • [29] Gender differences in prevalence of anemia and cardiovascular disease in patients with CKD
    McClellan, W
    Bhaduri, S
    Klausner, M
    Tang, L
    Mazzola, E
    Mody, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 43 (04) : A31 - A31
  • [30] Impact of Diabetes-Related Distress on Predicted Cardiovascular Complications in Patients with Type 2 Diabetes
    Young, Clipper
    Dugan, Joy A.
    Ray, Andrew J.
    Shubrook, Jay H.
    DIABETES, 2018, 67
12345